Visto files patent infringement lawsuit against Smartner
Posted on 1-Mar-2005 08:16
| Filed under: News
Visto Corporation had filed a complaint alleging patent infringements against Smartner Information Systems Ltd. The complaint, filed in the U.S. District Court for the Eastern District of Texas, seeks a permanent injunction that would prohibit Smartner from continuing to marketing its services in the United States. Visto will also seek monetary damages as compensation for Smartner's illegal actions.
Both companies offer secure push e-mail for mobile devices like Windows Mobile Pocket PC, Windows Mobile Smartphone and Symbian smartphones.
"With over 22 patents worldwide, Visto is driving progress and advancement in the push email and personal information market," said Daniel Mendez, vice president and CTO of Visto Corporation. "Smartner's attempt to misappropriate our industry-leading technology for their own gain hinders fair competition, inhibits true innovation, and ultimately creates confusion among customers and partners. We will continue to lead by aggressively investing in research and development and will vigorously pursue companies such as Smartner that attempt to misuse or exploit our intellectual property."
Visto asserts that Smartner Information Systems Ltd. is infringing on five of its patents: US patent nos. 6,085,192 and 6,023,708, which describe systems and methods for securely synchronizing multiple copies of a workspace element in a network, and the use of a global translator to synchronize workspace elements across a network. Patent No. 5,961,590 entitled, "System and Method for Synchronizing Electronic Mail Between a Client Site and a Central Site", Patent No. 5,968,131, entitled "System and Method for Securely Synchronizing Multiple Copies of a Workspace Element in a Network" and Patent No. 6,708,221 entitled, "System and Method for Globally and Securely Accessing Unified Information in a Computer Network".
Visto currently holds 22 patents in the United States, Japan, China, Hong Kong, Singapore and Israel. Dozens of other patents are pending in Europe and worldwide.